Journal article
A roundtable on responsible innovation with autologous stem cells in Australia, Japan and Singapore
T LYSAGHT, M MUNSIE, ADAM CASTRICUM, JHP HUI, K OKADA, YOJI SATO, Y SAWA, C STEWART, LK TAN, LHY TAN, S SUGII
Cytotherapy | ELSEVIER SCI LTD | Published : 2018
Abstract
We report on a roundtable event hosted in Singapore that sought to identify some of the ethical and regulatory challenges in translating autologous cell-based interventions, particularly those claiming to involve stem cells, into safe and effective therapies and to propose some solutions to encourage responsible innovation with these products. Challenges are identified in the three areas of cell manufacturing and processing, innovative uses of autologous cells in clinical practice and standards of evidence. Proposed solutions are discussed within a co-operative model of statutory laws and regulations that can enable product development with autologous cells and professional codes and standar..
View full abstractGrants
Awarded by Australian Research Council
Funding Acknowledgements
This roundtable was organised by the Centre for Biomedical Ethics at the National University of Singapore in collaboration with the Stem Cell Society, Singapore, the Sydney Law School and the Centre for Stem Cell Systems, University of Melbourne, with funding from the Humanities and Social Sciences Fund of the Office of Deputy President (Research and Technology), National University of Singapore (WBS: R-171-000-055-646) and an Australian Research Council Linkage Project Grant (LP150100739). We thank all the roundtable speakers and participants for generously sharing their knowledge, research and professional insights.